https://openbell.ai/ 2026-10-06T11:37:21.941Z hourly 1.0 https://openbell.ai/support 2026-10-06T11:37:21.941Z monthly 0.7 https://openbell.ai/privacy 2026-10-06T11:37:21.941Z monthly 0.5 https://openbell.ai/terms 2026-10-06T11:37:21.941Z monthly 0.5 https://openbell.ai/feed.json 2026-10-06T11:37:21.941Z hourly 0.8 https://openbell.ai/news/CEG:1791286617950 2026-10-06T11:36:57.950Z daily 0.9 https://cdn.brandfetch.io/CEG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Constellation Stock Rises 7% After Google Deal Unlocks $4.3 Billion Nuclear Investment Amid AI Power Boom (UPDATED) Constellation Energy Corp. (NASDAQ: CEG) shares rose 7.16% to $286.78 following a long-term partnership with Alphabet Inc. (NASDAQ: GOOG) to supply nuclear energy, which includes a 20-year power purchase agreement worth over $4.3 billion for upgrades at 11 nuclear units. The deal will add 890 MW of capacity to the PJM grid and is expected to support approximately 4,400 existing jobs and create around 7,200 construction jobs. Additionally, Constellation has expanded its nuclear generation plans with a 15-year agreement for an extra 2,700 MW to the PJM market and a technology alliance with Google Cloud to utilize AI in optimizing power generation. https://openbell.ai/news/ARAI:1791286547500 2026-10-06T11:35:47.500Z daily 0.9 https://cdn.brandfetch.io/ARAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Arrive AI Announces $0.65 Per Unit Investment From Undisclosed Specialized Private Investment Firm Arrive AI Inc. (NASDAQ: ARAI) announced a direct investment priced at $0.65 per unit from a specialized private investment firm, representing a 213% premium over its recent trading price of $0.2075. Each unit consists of one share of common stock and one warrant, with the warrants exercisable at $0.70 per share. This investment reflects the investor's confidence in Arrive AI's outlook and long-term growth potential. https://openbell.ai/news/CEG:1791286532717 2026-10-06T11:35:32.717Z daily 0.9 https://cdn.brandfetch.io/CEG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Constellation Stock Rises 7% After Google Deal Unlocks $4.3 Billion Nuclear Investment Amid AI Power Boom (UPDATED) Constellation Energy Corp. (NASDAQ: CEG) shares rose 7.16% to $286.78 following a long-term power purchase agreement with Alphabet Inc. (NASDAQ: GOOG) to supply nuclear energy, which will unlock over $4.3 billion in upgrades across 11 nuclear units. The 20-year deal aims to add 890 MW of new capacity to the PJM grid, supporting rising electricity demand and creating approximately 7,200 construction jobs. Additionally, Constellation has expanded its nuclear generation plans with a 15-year agreement to supply an extra 2,700 MW to the PJM market and enhanced its technology alliance with Google Cloud to leverage AI for optimizing power generation. https://openbell.ai/news/NVDA:1791286523658 2026-10-06T11:35:23.658Z daily 0.9 https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Think NVIDIA's AI Boom Is Priced In? Analyst Says Wall Street Is Underestimating the Next 6 to 8 Quarters NVIDIA Corp. is experiencing significant growth, approaching a $6 trillion market capitalization after a nearly 30% increase in 2026, driven by rising demand for AI infrastructure and enterprise adoption. The company has expanded its share repurchase authorization by $150 billion, now totaling approximately $235 billion through fiscal 2028, reflecting strong cash generation and confidence in future AI demand. Analysts, including Dan Ives, suggest that Wall Street may be underestimating NVIDIA's growth potential by 25-30% over the next year, citing tight supply-demand conditions and increasing enterprise AI spending. NVIDIA shares are currently trading at a new 52-week high of $241.07, up 0.91% in premarket trading. https://openbell.ai/news/ELPW:1791286501523 2026-10-06T11:35:01.523Z daily 0.9 https://cdn.brandfetch.io/ELPW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Elong Power Holding H1 EPS $(42.36) Down From $1.65 thousand YoY, Sales $2.899M Up From $19.229K YoY Elong Power Holding (NASDAQ: ELPW) reported a loss of $(42.36) per share for the first half of the year, a significant decline from earnings of $1.65 thousand per share in the same period last year, representing a 102.57% decrease. The company's sales reached $2.899 million, marking a substantial increase of 14,980% compared to $19.229 thousand in the previous year. https://openbell.ai/news/SAFX:1791286483249 2026-10-06T11:34:43.249Z daily 0.9 https://cdn.brandfetch.io/SAFX/w/400/h/400?c=1idopYfmtR7ZKg8QMud XCF Global Shareholders Approve Proposed Merger With DevvStream, Southern Energy Renewables XCF Global Inc. (NASDAQ: SAFX) has received shareholder approval for its merger with DevvStream Corp. (OTC: DEVSF) and Southern Energy Renewables Inc. This approval marks a significant milestone in the business combination process and indicates strong support from shareholders for the amended transaction structure. https://openbell.ai/news/TW:1791286400398 2026-10-06T11:33:20.398Z daily 0.9 https://cdn.brandfetch.io/TW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tradeweb Reports September Average Daily Volume Of $3.7T, Up 29.0%; Q3 ADV Of $3.2T, Up 22.4% openbell Financial News https://openbell.ai/news/NXAT:1791286373222 2026-10-06T11:32:53.222Z daily 0.9 https://cdn.brandfetch.io/NXAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nexus Advanced Technologies Signs Exclusivity Agreement To Negotiate Potential $500M Reverse Merger With US Defense Technology Company Nexus Advanced Technologies Inc. (NASDAQ: NXAT) has signed an exclusivity agreement to negotiate a potential reverse merger with a U.S. defense technology company, valued at approximately $500 million. The Target, which specializes in counter-drone defense technology, has received non-binding letters of intent for projects worth around $7 billion. The transaction may involve a merger with a subsidiary of Nexus, leading to a change of control, but final terms are still under negotiation. https://openbell.ai/news/ZTS:1791286363375 2026-10-06T11:32:43.375Z daily 0.9 https://cdn.brandfetch.io/ZTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Zoetis Says 25% Of Simparica Trio-Treated Dogs Had Adult Heartworms vs. 75% On NexGard Plus In Drug-Resistant Heartworm Study openbell Financial News https://openbell.ai/news/BBIO:1791286336811 2026-10-06T11:32:16.811Z daily 0.9 https://cdn.brandfetch.io/BBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud BridgeBio Pharma Receives FDA Acceptance For Filing Its New Drug Application With Priority Review For Oral Infigratinib To Treat Achondroplasia BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced that the FDA has accepted its New Drug Application for oral infigratinib, aimed at treating children with achondroplasia, with Priority Review status. The FDA has set a target action date of February 4, 2027, for the Prescription Drug User Fee Act (PDUFA). BridgeBio is prepared to launch the drug upon approval. https://openbell.ai/news/NYAX:1791286325861 2026-10-06T11:32:05.861Z daily 0.9 https://cdn.brandfetch.io/NYAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nayax Announces Distribution Partnership With Allied Electronics For VPOS Media 5 Payment Terminal At U.S. Fuel Retailers; Terms Not Disclosed openbell Financial News https://openbell.ai/news/KAPA:1791286288220 2026-10-06T11:31:28.220Z daily 0.9 https://cdn.brandfetch.io/KAPA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kairos Pharma Reports 17.7-Month Median Progression-Free Survival vs. 2 Months In Interim Phase 2 ENV-105 Prostate Cancer Data openbell Financial News https://openbell.ai/news/SCYX:1791286275657 2026-10-06T11:31:15.657Z daily 0.9 https://cdn.brandfetch.io/SCYX/w/400/h/400?c=1idopYfmtR7ZKg8QMud SCYNEXIS Completes Phase 1 Study Of SCY-770, Selective And Direct AMP-Activated Protein Kinase Activator SCYNEXIS, Inc. has completed a Phase 1 study of SCY-770, a selective and direct AMP-activated protein kinase activator, which demonstrated a favorable safety profile in healthy adult participants. The company plans to initiate a Phase 2 proof-of-concept study in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the fourth quarter of 2026. SCY-770 aims to address multiple drivers of cyst growth and disease progression in ADPKD. https://openbell.ai/news/SPWR:1791286273438 2026-10-06T11:31:13.438Z daily 0.9 https://cdn.brandfetch.io/SPWR/w/400/h/400?c=1idopYfmtR7ZKg8QMud SunPower Commences Construction For Solar Power System For New AI Data Center In Reno, Nevada SunPower Inc. (Nasdaq: SPWR) has commenced construction on a solar power system for a new AI data center in Reno, Nevada. This project marks a significant step in the company's efforts to expand its renewable energy solutions. https://openbell.ai/news/IPDN:1791286147893 2026-10-06T11:29:07.893Z daily 0.9 https://cdn.brandfetch.io/IPDN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Professional Diversity Network's PDN Intelligence Subsidiary Inks Lease Deal With Goodwill Labs, HashForest Technology For ~$1.177B Of Initial Capital Commitments For Two Nvidia B300 Eight-GPU Systems Professional Diversity Network's subsidiary, PDN Intelligence, has signed a lease agreement with Goodwill Labs and HashForest Technology, involving approximately $1.177 billion in initial capital commitments. The deal includes the acquisition of two Nvidia B300 eight-GPU systems. This strategic move is expected to enhance PDN Intelligence's technological capabilities. https://openbell.ai/news/IPDN:1791286116920 2026-10-06T11:28:36.920Z daily 0.9 https://cdn.brandfetch.io/IPDN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Professional Diversity Network's PDN Intelligence Subsidiary Inks Lease Deal With Goodwill Labs, HashForest Technology For ~$1.177B Of Initial Capital Commitments For Two Nvidia B300 Eight-GPU Systems Professional Diversity Network's subsidiary, PDN Intelligence, has signed a lease agreement with Goodwill Labs and HashForest Technology, which involves approximately $1.177 billion in initial capital commitments. The deal includes the acquisition of two Nvidia B300 eight-GPU systems. This strategic move is expected to enhance PDN Intelligence's technological capabilities. https://openbell.ai/news/EDBL:1791285552094 2026-10-06T11:19:12.094Z daily 0.9 https://cdn.brandfetch.io/EDBL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Edible Garden Awarded New Fresh Herb Program With Walmart For Upcoming Thanksgiving Through New Year Holiday Season Edible Garden AG Incorporated (NASDAQ: EDBL) has been awarded a new fresh herb program with Walmart for the Thanksgiving through New Year holiday season, enhancing its existing distribution with the retailer. This program adds incremental business and follows the recent awarding of three additional Walmart distribution centers, solidifying Edible Garden's presence in key markets such as the Midwest, Mid-Atlantic, and Northeast. The partnership aims to leverage Walmart's extensive retail network to increase market share for Edible Garden's fresh herb offerings. https://openbell.ai/news/BA:1791285519603 2026-10-06T11:18:39.603Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Boeing-airplane.jpg?width=250&height=187 Boeing Wins $14.7 Billion PAC-3 Seeker Production Contract From Lockheed Boeing has secured a $14.7 billion contract from Lockheed Martin to produce PAC-3 MSE seekers, which will triple output under a seven-year agreement with the U.S. Department of Defense. This contract is expected to create hundreds of jobs in Huntsville, Alabama, as Boeing enhances its production capabilities. The company has invested in upgrading facilities and improving manufacturing processes to support this increased production. Boeing's stock was trading at $193.57, up 0.44% in premarket trading. https://openbell.ai/news/BLNE:1791285505908 2026-10-06T11:18:25.908Z daily 0.9 https://cdn.brandfetch.io/BLNE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Beeline Sees Q3 Sales At Second-Highest Quarterly Result In Company History And Highest Since 2021, Will Achieve Highest Margins In Company History; Expects Q3 Net Loss To Be Lower Than Q2 Net Loss Beeline Holdings, Inc. (NASDAQ: BLNE) anticipates its Q3 2026 revenue to be the second-highest in company history and the highest since 2021, alongside achieving the highest margins ever. The company expects its Q3 net loss to be lower than in Q2 2026, with adjusted EBITDA loss improving to the lowest level in five years. Additionally, Beeline plans to launch a Home Equity Investment product to diversify its offerings and reduce reliance on traditional mortgage cycles, while expecting a cash position at least 50% higher than at the end of Q2 2026. https://openbell.ai/news/CEG:1791285384966 2026-10-06T11:16:24.966Z daily 0.9 https://cdn.brandfetch.io/CEG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Constellation Stock Rises 7% After Google Deal Unlocks $4.3 Billion Nuclear Investment Amid AI Power Boom (UPDATED) Constellation Energy Corp. (NASDAQ: CEG) announced a long-term partnership with Alphabet Inc. (NASDAQ: GOOG) to add 890 MW of new nuclear capacity to the PJM grid, which will involve over $4.3 billion in upgrades at 11 nuclear units across Illinois, Pennsylvania, and New Jersey. Following the announcement, Constellation's stock rose 7.16% to $286.78 in premarket trading. The agreement is expected to support approximately 4,400 existing jobs and create around 7,200 construction jobs, while also expanding Constellation's nuclear generation plans with a 15-year agreement to supply an additional 2,700 MW to the PJM market. https://openbell.ai/news/NEO:1791285178584 2026-10-06T11:12:58.584Z daily 0.9 https://cdn.brandfetch.io/NEO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Maintains Buy on NeoGenomics, Raises Price Target to $22 Needham analyst Mike Matson has maintained a 'Buy' rating on NeoGenomics (NASDAQ: NEO) and raised the price target from $19 to $22. This adjustment reflects a positive outlook for the company's performance in the market. https://openbell.ai/news/ZETA:1791285077375 2026-10-06T11:11:17.375Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Zeta-Global-company-logo-displayed-on-mo.jpg?width=250&height=187 Zeta Global Adds Senso to Its AI Arsenal Zeta Global Holdings Corp. has entered into a definitive agreement to acquire Senso, a Y Combinator-backed AI engineering company, enhancing its Generative Engine Optimization offering. The acquisition aims to strengthen Zeta's AI trust and discoverability tools, integrating Senso's technology with Zeta's Data Cloud. As of June 30, 2026, Zeta reported $309.95 million in cash and recently closed a $1 billion credit facility to support acquisitions and corporate purposes. Zeta's stock was trading at $33.29, up 1.25% in premarket trading, and is near its 52-week high of $34.80. https://openbell.ai/news/USB:1791285006713 2026-10-06T11:10:06.713Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Richfield--Mnusa---June-21--2014-Us-Bank.jpg?width=250&height=187 U.S. Bancorp Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call U.S. Bancorp (NYSE: USB) is set to report its Q3 earnings on October 15, with analysts expecting earnings of $1.31 per share, an increase from $1.22 per share a year ago. The consensus revenue estimate is $8 billion, up from $7.33 billion in the previous year. The company declared a quarterly dividend of 54 cents per share on September 8, while its stock closed at $57.27, down 0.4% on Monday. https://openbell.ai/news/VKTX:1791284969810 2026-10-06T11:09:29.810Z daily 0.9 https://cdn.brandfetch.io/VKTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Viking Therapeutics Begins Exploratory Oral Maintenance Dosing Study Of VK2735, Its Dual Agonist Of Glucagon-Like Peptide 1 And Glucose-Dependent Insulinotropic Polypeptide Receptors Viking Therapeutics has initiated an exploratory oral maintenance dosing study for VK2735, a dual agonist targeting GLP-1 and GIP receptors, aimed at treating metabolic disorders like obesity. This trial is the second part of a two-part maintenance study, following positive results from Part 1, which tested subcutaneous dosing regimens. The current study involves approximately 195 healthy adults with obesity and will evaluate various dosing regimens for safety, tolerability, and pharmacokinetics, while also assessing weight changes from baseline to Week 33. https://openbell.ai/news/CSIQ:1791284899515 2026-10-06T11:08:19.515Z daily 0.9 https://cdn.brandfetch.io/CSIQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Canadian Solar Signs Agreement To Supply And Commission 100 MW/200 MWh Battery Energy Storage System For OX2's Muswellbrook Solar Farm And Battery, Solar-Plus-Storage Project In New South Wales, Australia Canadian Solar Inc. has signed an agreement through its e‑STORAGE division to supply and commission a 100 MW/200 MWh battery energy storage system for OX2's Muswellbrook Solar Farm and Battery project in New South Wales, Australia. Shipments are set to begin in Q3 2027, with commercial operations expected by Q3 2028. The project includes a 20-year long-term service agreement and aims to enhance grid reliability by converting solar energy into a firm, contracted supply, addressing the region's transition from coal power. https://openbell.ai/news/KMDA:1791284792444 2026-10-06T11:06:32.444Z daily 0.9 https://cdn.brandfetch.io/KMDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kamada Expands Biosimilar Portfolio With Commercial Launch Of Two Additional New Products In Israel, Adding To Existing Portfolio Of Two Products Kamada Ltd. has expanded its biosimilar portfolio with the commercial launch of two new products in Israel: Ustekinumab-Kamada and Enoxaparin-Kamada, adding to its existing two biosimilars. The company anticipates its biosimilar portfolio will generate approximately $4 million in sales by 2026, increasing to $10 million by 2028, and aims to have at least 12 marketed products by 2030, potentially generating $20 million to $25 million in annual revenue. All four biosimilars are approved as interchangeable with their reference biologics. https://openbell.ai/news/ELTK:1791284773652 2026-10-06T11:06:13.652Z daily 0.9 https://cdn.brandfetch.io/ELTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Eltek Receives $6.8M Of Follow-On Orders From An International Customer For Delivery Throughout 2027 And 2028 openbell Financial News https://openbell.ai/news/OKYO:1791284727273 2026-10-06T11:05:27.273Z daily 0.9 https://cdn.brandfetch.io/OKYO/w/400/h/400?c=1idopYfmtR7ZKg8QMud OKYO Pharma Announces First Patients Enrolled In Phase 3 NEPTUNE Trial Of Urcosimod For Neuropathic Corneal Pain OKYO Pharma Limited has enrolled the first patients in its Phase 3 NEPTUNE trial for urcosimod, aimed at treating neuropathic corneal pain (NCP), a condition with no FDA-approved treatments. The enrollment was conducted by Dr. Melissa Toyos at Toyos Clinic in Nashville, TN. This trial represents a significant step for OKYO in addressing a major unmet medical need in ocular health. https://openbell.ai/news/XNDU:1791284682945 2026-10-06T11:04:42.945Z daily 0.9 https://cdn.brandfetch.io/XNDU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Xanadu Quantum Technologies Enters Multi-Year Partnership With GlobalFoundries To Develop High-Volume Production For Utility-Scale Quantum Computing Xanadu Quantum Technologies has entered a multi-year partnership with GlobalFoundries to enhance the high-volume production of advanced photonic components for utility-scale quantum computing. The collaboration will leverage Xanadu's expertise in ultra-low loss photonic design and GF's manufacturing capabilities at its 300 mm production line in Malta, New York, focusing initially on the industrialization of Superconducting Nanowire Single-Photon Detectors (SNSPDs) and ultra-low-loss silicon nitride (SiN) photonics. This partnership aims to transition from lab-scale prototyping to industrial-grade production, ultimately supporting Xanadu's goal of developing hardware for future quantum data centers. https://openbell.ai/news/PDYN:1791284667808 2026-10-06T11:04:27.808Z daily 0.9 https://cdn.brandfetch.io/PDYN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Palladyne AI’s Edge AI Flight Computer BRAIN Selected As Finalist In US Army FUZE xTech|Apex Intercept Competition Palladyne AI Corp. (NASDAQ: PDYN) has been selected as a finalist in the U.S. Army's FUZE xTech|Apex Intercept competition for its edge AI flight computer, BRAIN. This selection allows the company to showcase BRAIN's capabilities in enhancing interceptor and fire-control technologies, which the Army is exploring to address complex aerial threats. The evaluation pathway aims to accelerate the development of low-cost, scalable defense solutions. https://openbell.ai/news/ACM:1791284245351 2026-10-06T10:57:25.351Z daily 0.9 https://cdn.brandfetch.io/ACM/w/400/h/400?c=1idopYfmtR7ZKg8QMud AECOM-Led JV, 413 Continuity Partners, Awarded Highway 413 Program Management Consultant Contract By Ministry Of Transportation Of Ontario AECOM, through its joint venture 413 Continuity Partners, has been awarded a contract by the Ministry of Transportation of Ontario to manage the Highway 413 program. This project involves creating a new 59-kilometer transportation corridor, including over 170 bridges and 60 culverts, aimed at improving connectivity and reducing congestion in the Greater Toronto Area. The 10-year contract will see 413 Continuity Partners provide various services including program management and construction oversight, leveraging AECOM's extensive experience in Canadian infrastructure projects. https://openbell.ai/news/MSFT:1791284148734 2026-10-06T10:55:48.734Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Microsoft-Copilot-AI-Logo-On-Smartphone.jpg?width=250&height=187 Jim Cramer Says Microsoft Is One of AI’s ‘Big Winners’ As Copilot Momentum Builds Microsoft Corp. is expanding its Copilot product into a comprehensive AI platform, aiming to enhance revenue from Microsoft 365 and Azure. The company is increasing its data center capacity to meet rising AI demand, with a reported $145 billion spent on capital expenditures in the last fiscal year. Analyst Brian Schwartz from Oppenheimer raised Microsoft's price target from $515 to $570, citing potential growth in Azure and Microsoft 365. As of Tuesday premarket trading, Microsoft shares were up 0.46% at $527.62. https://openbell.ai/news/GOOGL:1791284015065 2026-10-06T10:53:35.065Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Mountain-View--Ca--Usa---January-24--202.jpg?width=250&height=187 Google and Constellation Energy Near $1 Billion Nuclear Power Deal as AI Data Centers Drive Power Demand: Report Alphabet Inc. (NASDAQ: GOOG) is nearing a multi-year agreement to purchase nuclear energy from Constellation Energy Corp. (NASDAQ: CEG) for $1 billion or more, driven by increasing power demands for AI data centers. The deal is expected to be announced this week, although specific details regarding the nuclear capacity and deal scale have not been disclosed. Constellation Energy's stock has seen a year-to-date decline of 24.24%, but closed 3.93% higher at $267.62 on Monday. https://openbell.ai/news/MIAX:1791283698159 2026-10-06T10:48:18.159Z daily 0.9 https://cdn.brandfetch.io/MIAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud MIAX Exchange Group Reaches YTD Average Daily Volume Of 11M Contracts Through September 2026, 22% Increase From Prior Year MIAX Exchange Group reported a year-to-date average daily volume (ADV) of 11.0 million contracts through September 2026, marking a 22.0% increase from the same period in 2025. Additionally, the group achieved a record market share of 17.1%, up from 16.7% in the previous year. https://openbell.ai/news/BETR:1791283504595 2026-10-06T10:45:04.595Z daily 0.9 https://cdn.brandfetch.io/BETR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Reiterates Buy on Better Home & Finance, Maintains $25 Price Target Needham analyst Kyle Peterson has reiterated a Buy rating on Better Home & Finance (NASDAQ: BETR) and maintained a price target of $25 for the stock. No additional financial figures or strategic changes were mentioned in the article. https://openbell.ai/news/RUBI:1791283478589 2026-10-06T10:44:38.589Z daily 0.9 https://cdn.brandfetch.io/RUBI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rubico Shares Trading Tuesday Following Effectiveness Of Previously Announced 0.50 Common Share Stock Dividend For Each Common Share Outstanding openbell Financial News https://openbell.ai/news/RZLT:1791283355057 2026-10-06T10:42:35.057Z daily 0.9 https://cdn.brandfetch.io/RZLT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cantor Fitzgerald Upgrades Rezolute to Overweight Cantor Fitzgerald analyst Pete Stavropoulos has upgraded Rezolute (NASDAQ: RZLT) from a Neutral rating to Overweight. This change reflects a more favorable outlook on the company's performance. https://openbell.ai/news/BD:1791283210656 2026-10-06T10:40:10.656Z daily 0.9 https://cdn.brandfetch.io/BD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Becton Dickinson To Invest $3B U.S. Domestic Manufacturing To Expand Output By 5B Medical Consumables Per Year; Will Invest $19B In The U.S. Over Several Years Becton Dickinson (BD) plans to invest $19 billion in the U.S. over several years, with $3 billion specifically allocated for expanding domestic manufacturing. This expansion aims to increase production by approximately 5 billion essential medical consumables annually, raising BD's domestic supply share to about 80%. Additionally, BD will manufacture all needles used in America with American-made steel. The agreement also includes provisions for relief from future tariffs on certain products, although the financial impact of these tariffs has not yet been quantified. https://openbell.ai/news/BESS:1791283135186 2026-10-06T10:38:55.186Z daily 0.9 https://cdn.brandfetch.io/BESS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bimergen Energy Highlights Q2 Revenue Of $7.9M, Net Income Of $1.6M, Completes $13.6M NYSE Uplisting Offering And Boosts Cash To $9.4M Bimergen Energy (NYSE: BESS) reported Q2 2026 revenue of $7.9 million and net income of $1.6 million, marking its first-ever GAAP profitability. The company completed a $13.6 million public offering and uplisted to NYSE American, increasing its cash reserves to approximately $9.4 million, up from $0.4 million at the end of 2025. Additionally, working capital improved significantly to +$9.6 million from -$4.5 million. https://openbell.ai/news/GOOGL:1791283107830 2026-10-06T10:38:27.830Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Stuttgart--Germany---July-20--2023-Googl.jpg?width=250&height=187 Google Unleashes AI on Aging Enterprise Tech With New Cloud Modernization Suite Alphabet Inc. has launched the Google Cloud Modernize suite, aimed at helping enterprises modernize their infrastructure and applications using AI, which includes tools like Migration Center and the EKS-to-GKE Migration Agent. The company also introduced new infrastructure to support demanding enterprise workloads, including the X5 Series for SAP configurations and M4N Series for database workloads. Despite these advancements, Alphabet faces increased competition in consumer AI, particularly from Meta Platforms, which has gained significant traction with its personal AI agents. Alphabet's shares were up 0.42% at $345.26 in premarket trading. https://openbell.ai/news/ZGN:1791283014963 2026-10-06T10:36:54.963Z daily 0.9 https://cdn.brandfetch.io/ZGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud HSBC Initiates Coverage On Ermenegildo Zegna with Buy Rating, Announces Price Target of $16 HSBC analyst Bhumi Kanabar has initiated coverage on Ermenegildo Zegna (NYSE: ZGN) with a Buy rating. The firm has set a price target of $16 for the stock. https://openbell.ai/news/BJDX:1791282972947 2026-10-06T10:36:12.947Z daily 0.9 https://cdn.brandfetch.io/BJDX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bluejay Diagnostics Reports SYMON-II Baseline Data Showing Diverse Critically Ill Sepsis Population And Meaningful Mortality Events Supporting IL-6 Evaluation For 28-Day Mortality Risk Bluejay Diagnostics, Inc. (NASDAQ: BJDX) reported baseline data from its SYMON-II clinical validation study, which includes 777 evaluable patients with an overall 28-day mortality rate of approximately 18%. The study highlighted a diverse population of critically ill patients, with 39.5% meeting Sepsis-3 criteria for septic shock. Among non-survivors, 56.4% had septic shock, indicating greater baseline illness severity compared to survivors. The findings support the evaluation of interleukin-6 (IL-6) as a biomarker for 28-day mortality risk in sepsis patients. https://openbell.ai/news/XP:1791282930558 2026-10-06T10:35:30.558Z daily 0.9 https://cdn.brandfetch.io/XP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Itau BBA Upgrades XP to Outperform, Announces $27 Price Target Itau BBA analyst Pedro Leduc has upgraded XP (NASDAQ: XP) from Market Perform to Outperform, setting a price target of $27 for the stock. This upgrade indicates a positive outlook for XP's performance in the market. https://openbell.ai/news/SRFM:1791282852236 2026-10-06T10:34:12.236Z daily 0.9 https://cdn.brandfetch.io/SRFM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Surf Air Mobility Signs Definitive Agreement With Clipper Aviation For OperatorOS, Surf Air Mobility's SurfOS Flight Operations Software For Part 135 Operators Powered By Palantir Surf Air Mobility has signed a definitive agreement with Clipper Aviation for its OperatorOS flight operations software, marking the fourth such contract for the company. This agreement aims to help Surf Air Mobility achieve its goal of having five operators using the platform by the end of 2026. The company will earn a percentage of revenue from all Clipper Aviation flights managed through the OperatorOS software. https://openbell.ai/news/CEG:1791282780067 2026-10-06T10:33:00.067Z daily 0.9 https://cdn.brandfetch.io/CEG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Google And Constellation Energy Announce Long-Term Strategic Clean Energy Collaboration To Bring 890 MW Of Reliable Nuclear Capacity Onto PJM Interconnection Grid To Meet Growing Demand And Increase Grid Reliability Google and Constellation Energy have announced a long-term collaboration to add 890 megawatts (MW) of nuclear capacity to the PJM Interconnection grid through a 20-year power purchase agreement. This initiative will involve investments exceeding $4.3 billion in new technology at 11 nuclear units, sustaining approximately 4,400 jobs and creating around 7,200 construction jobs. Additionally, the partnership includes a 15-year energy supply agreement for an extra 2,700 MW and a five-year technology alliance to implement AI solutions for energy management. https://openbell.ai/news/LMT:1791282689829 2026-10-06T10:31:29.829Z daily 0.9 https://cdn.brandfetch.io/LMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rothschild & Co Initiates Coverage On Lockheed Martin with Buy Rating, Announces Price Target of $650 Rothschild & Co has initiated coverage on Lockheed Martin (NYSE: LMT) with a Buy rating. The firm has set a price target of $650 for the company's stock. https://openbell.ai/news/TLX:1791282684382 2026-10-06T10:31:24.382Z daily 0.9 https://cdn.brandfetch.io/TLX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Telix Pharmaceuticals Says First Patients In US Dosed With Pixclara, FDA-Approved, Amino Acid Positron Emission Tomography Drug For Glioma Imaging Telix Pharmaceuticals has announced the first doses of its FDA-approved drug Pixclara, an amino acid positron emission tomography (PET) agent for glioma imaging, have been administered in the U.S. at facilities in Cleveland and Indianapolis. This marks the beginning of Pixclara's commercial availability in the U.S., with PharmaLogic Holdings Corp. as the distribution partner. Pixclara is designed to help differentiate recurrent or progressive glioma from treatment-related changes in patients aged one month and older. https://openbell.ai/news/BTC:1791282662511 2026-10-06T10:31:02.511Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Hunter-Biden-Addressed-The-Media-On-Dece.jpg?width=250&height=187 Hunter Biden Says America’s Dollar Is ‘Fake’ Under Fiat System, Warns Inflation Is Built in When Government Can Print Money ‘at Will’ Hunter Biden criticized the U.S. dollar, labeling it 'fake' and asserting that inflation acts as a built-in tax under the fiat monetary system. He emphasized his pro-Bitcoin stance, stating that 'fiat is a sham' and predicting Bitcoin could reach $220,000 by 2028. Biden's recent comments align with his previous views on cryptocurrency and reflect a growing alignment with the Bitcoin community, particularly following the launch of his LAPTOP token in September. https://openbell.ai/news/APOG:1791282657899 2026-10-06T10:30:57.899Z daily 0.9 https://cdn.brandfetch.io/APOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Apogee Enterprises Raises FY2027 Adj EPS Guidance from $2.70-$3.25 to $3.00-$3.40 vs $2.92 Est; Raises FY2027 Sales Guidance from $1.380B-$1.430B to $1.460B-$1.500B vs $1.458B Est Apogee Enterprises has raised its fiscal year 2027 adjusted EPS guidance from a range of $2.70-$3.25 to $3.00-$3.40, surpassing the analyst estimate of $2.92. Additionally, the company increased its sales outlook for FY2027 from $1.380 billion-$1.430 billion to $1.460 billion-$1.500 billion, slightly above the $1.458 billion estimate. https://openbell.ai/news/APOG:1791282656162 2026-10-06T10:30:56.162Z daily 0.9 https://cdn.brandfetch.io/APOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Apogee Enterprises Q2 Adj. EPS $1.17 Beats $0.63 Estimate, Sales $391.135M Beat $359.464M Estimate Apogee Enterprises reported Q2 adjusted earnings per share of $1.17, surpassing the analyst estimate of $0.63 by 85.71%. This represents a 19.39% increase compared to $0.98 per share from the same quarter last year. The company's sales reached $391.135 million, exceeding the expected $359.464 million by 8.81%, and marking a 9.20% increase from $358.194 million in the prior year.